Autophagy-mediated Secretion of Intracellular Antigens Co-opts Antibody Responses to Drive Neutrophil-Dependent Tumor Progression
Yanfeng Liu, Qianqian Zhang, Yidan Gao, Yiming Long, Xuan Tao, Xiaonuo Ma, Juan He, Weiyu Jiang, Yifei Qian, Qianyu Li, Wei Wu, Fan Cao, Anqi Xia, Yingying Guo, Minxiang Xie, Thiago Y. Oliveira, Israel Tojal Da Silva, Wenjing Su, Shibo Jiang, Yanan Wang, Dong Gao, Yixiao Zhang, Pengli Zheng, Qiao WangAbstract
How intracellular proteins, normally hidden from the immune system, become targets of tumor-associated antibody responses remains unresolved, as does the function of such autoantibodies encoded by tumor-infiltrating B cells (TIL-Bs). Using monoclonal antibodies (mAbs) cloned from TIL-Bs in a spontaneous hepatocellular carcinoma (HCC) model, we define a class of antigens: secreted intracellular antigens (SICAs). Tumors co-opt upregulated autophagy to release cytosolic proteins, exemplified by ALDH1L1, through HSP90-mediated autophagy-dependent unconventional secretion. The resulting autoantibodies form immune complexes at the tumor site, where the SICA is locally available, recruiting and reprogramming neutrophils into tumor-associated neutrophils that drive tumor progression. Both neutrophil depletion and loss of Fcγ receptor binding abolish this effect. Autophagy-mediated SICA secretion and the corresponding autoantibody response are conserved in HCC patients and extend to lung, breast and cervical cancers. Tumors thus reshape their secretome to hijack humoral immunity, highlighting the SICA–autoantibody–FcγR axis as a potential therapeutic target.